NHERF1 and colorectal carcinoma: Finally, the researchers hypothesized that doubleβ-catenin/NHERF1-inhibitory strategy may be fruitful to augment the induction of apoptotic death in CRC cells refractory to Wnt/β-catenin-targeted therapeutics [99].